Pulsed Transcranial Ultrasound Stimulation Immediately After The Ischemic Brain Injury is Neuroprotective
Tengfei Guo, Hangdao Li, Yifan Lv, Hongyang Lu, Jinhai Niu, Junfeng Sun, Guo-Yuan Yang, Chuancheng Ren, Shanbao Tong
IEEE Transactions on Biomedical Engineering 2015, 62, 2352-2357 · 10.1109/tbme.2015.2427339
Abstract
Goal We applied a low-intensity pulsed transcranial ultrasound stimulation (pTUS) to the ischemic cortex after a distal middle cerebral artery occlusion (dMCAO) to study whether pTUS is capable of protecting brain from ischemic injury. Methods Rats were randomly assigned to Sham (n = 6), Control (n = 16), and pTUS (n = 16) groups. The pTUS-treated rats were subjected to 60-min ultrasonic stimulation immediately after the ischemia. After 48 h, the sensorimotor-related behavioral outcomes were assessed by a neurological severity score (NSS), and the permanent brain injury was assessed by the histologic analysis of TTC staining of brain slices. Results pTUS group showed significantly lower NSS (n = 10, 5.5 ± 2.5) than the Control group ( n = 10, 10.5 ±1.4) (p Conclusion Both behavior and histological results suggested that pTUS on ischemic core immediately after ischemic stroke could be neuroprotective. Significance The noninvasiveness and high spatiotemporal resolution of pTUS makes it a unique neuromodulation technique in comparison with the current TMS and tDCS.
Abstract via europepmc.
Exposures
Exposure 1: Collimated 0.5 MHz pTUS to ischemic/somatosensory cortex
Target: cerebral cortex — “ischemic cortex (ischemic core after distal MCAO); in a separate cerebral-blood-flow experiment, 'the overall somatosensory cortex'”
Device: Olympus / Panametrics · Olympus · V301
| Waveform | pulsed | |
|---|---|---|
| Fundamental frequency (kHz) | 500 | ✓✓✓ |
| Pulse duration (ms) | 0.4 | ✓✓✓⚑ |
| Pulse repetition frequency (Hz) | 1,500 | ✓✓✓ |
| Duty cycle (%) | not reportedpulse duration × PRF gives 60% | |
| Sonication duration (s) | 0.4, 0.67swept | ✓✓✓ |
| Free-field pressure (kPa) | not reported | |
|---|---|---|
| Free-field Isppa (W/cm²) | not reported | ⚑ |
| Free-field Ispta (W/cm²) | not reported | ⚑ |
| In-situ estimate | not reported | |
| In-situ pressure (kPa) | not reported | |
| In-situ Isppa (W/cm²) | not reported | |
| In-situ Ispta (W/cm²) | not reported | |
| Isppa, domain unspecified (W/cm²) | 2.16 | ✓✓✓ |
| Ispta, domain unspecified (W/cm²) | 0.086 | ✓✓✓ |
Each tone pulse comprised 200 acoustic cycles at 0.5 MHz (NC = 200) repeated at a tone-burst PRF of 1.5 kHz. In stroke experiments, 360 trials (0.4 s sonication per trial, 10 s intertrial interval) of collimated pTUS were delivered to the ischemic cortex immediately after dMCAO for a total of 60 min, using 600 tone bursts per trial (NTB = 600). In a separate cerebral-blood-flow experiment on non-ischemic rats, three blocks of 12 trials (2 min intertrial, 10 min interblock interval) were tested with NTB = 600, 800 or 1000, giving per-trial sonication durations of about 0.40-0.67 s. Ultrasound power was reported as spatial-average pulse-average (ISAPA, 2.155 W/cm2) and spatial-average temporal-average (ISATA, 43-86 mW/cm2 depending on NTB) intensities, not spatial-peak values.
Flags from extraction
exposures[0].timing.pulse_duration_ms— Not stated directly as a duration; computed via the permitted cycles-per-pulse / frequency conversion from NC = 200 acoustic cycles at 0.5 MHz.exposures[0].free_field.isppa_w_cm2— Paper reports only spatial-average intensities (ISAPA 2.155 W/cm2, ISATA 43-86 mW/cm2 depending on NTB), not the spatial-peak ISPPA/ISPTA quantities requested by this field; left not_reported rather than conflating spatial-average with spatial-peak intensity.exposures[0].free_field.ispta_w_cm2— Same as above: only spatial-average temporal-average intensity (ISATA) is reported, which is a distinct quantity from spatial-peak ISPTA.n_subjects— 38 rats were split into dMCAO-control (n=16, no ultrasound), dMCAO-pTUS (n=16, ultrasound-exposed) and Sham-surgery (n=6, no ultrasound, no dMCAO) groups; a separate cohort of 9 rats was used for the cerebral-blood-flow experiment. Only the 16 pTUS-treated stroke rats and the 9 CBF-experiment rats received ultrasound; these are recorded as two group sizes since the paper gives no combined total and it is unclear whether any animals overlap between experiments (e.g. the n=6 immunohistochemistry subset).sham_type— The paper's 'Sham' group refers to sham surgery for the stroke model (no dMCAO), not a sham/inactive-ultrasound condition; the ultrasound comparator ('Control') simply received no ultrasound device application, so sham_type is recorded as 'none'.